![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 01, 2009 5:44:53 AM
LOS ANGELES - May 01, 2009 - Sequenom Inc. (NASDAQ:SQNM) topped the list of biggest percentage price decliners among common stocks
on the Nasdaq Stock Market on Thursday.
Meanwhile, EXACT Sciences (NASDAQ:EXAS) is poised to continue its comeback from penny stock
levels late last year and has a chance to close the year at a higher market value than its molecular
diagnostics rival.
BiomedReports.Com reports on the interesting reversal of fortune for these two rivals whose ties run deep.
Months ago, Sequenom launched a hostile, all-stock tender offer for EXACT Sciences earlier this year for $1.50 per share (which would now be valued at less than 40 cents), but EXACT rejected the deal in favor of a strategic pact with Genzyme (NASDAQ:GENZ) which involved a $24.5M cash infusion.
SQNM was trading around 25 bucks in late January, but published news reports indicate that Sequenom publicized clinical data throughout 2008 and 2009, which it claimed confirmed the strong efficacy of Sequenom's prenatal genetic test for Down syndrome.
On April 29, 2009, Sequenom disclosed "employee mishandling" of the clinical data, which raised "significant concerns regarding the integrity of that data."
In the first hour of trading on Thursday, Sequenom shares plunged 77%, or $11.43, to $3.48 on 27 times its average daily volume over the past 30 days.
A full special report on the companies appears today at:
http://biomedreports.com/articles/most-popular/885-sequenom-splattered-exact-sciences-on-the-rise.html
Recent EXAS News
- Exact Sciences schedules second quarter 2024 earnings call • Business Wire • 07/08/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 11:00:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:01:05 AM
- Exact Sciences to Participate in June Investor Conferences • Business Wire • 05/28/2024 10:00:00 AM
- Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von Behandlungsergebnissen • Business Wire • 05/25/2024 11:32:00 AM
- Exact Sciences démontre son leadership continu en matière de diagnostic précoce du cancer et d’amélioration des résultats pour les patients grâce à de multiples présentations de données à l’ASCO® • Business Wire • 05/24/2024 04:46:00 PM
- Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO® • Business Wire • 05/24/2024 10:05:00 AM
- Exact Sciences Earns 2024 Great Place To Work® Certification™ • Business Wire • 05/22/2024 11:30:00 AM
- Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy • Business Wire • 05/21/2024 10:05:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 09:10:47 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 05/08/2024 09:08:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 09:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:08:13 PM
- Exact Sciences Announces First-Quarter 2024 Results • Business Wire • 05/08/2024 08:05:00 PM
- U.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices Fall • IH Market News • 05/08/2024 12:29:17 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM